MENU

3 healthcare companies with rocketing long-term growth

Healthcare stocks are likely to remain among the top growth companies over the next five years due to a favourable cocktail of demographic factors. Ageing populations, bulging middle classes in China and South-East Asia and growing populations will all drive increased spending on health related products and services.

And if this reporting season is anything to go by, the growth in the healthcare sector has already started flowing through thick and fast.

Healthcare and animal care distributor EBOS Group Ltd. (ASX: EBO) only listed on the ASX last year, but is already making a big impression, beating prospective forecasts and growing net profit after tax (NPAT) by 229%.

The company categorises itself as a growth company and is targeting both long-term organic growth and acquisitions. Ebos is currently looking at a number of acquisitions and is also in negotiations with the NZ government to set up a national supply chain for medical devices and consumables.

With a share price of $8 Ebos is trading at a trailing (2013) price-to-earnings ratio of around 16. This could turn out to be a long-term bargain.

Mask and breathing device maker ResMed Inc (ASX: RMD) is another quality company which continues to see sustained growth. For the second quarter of the 2014 financial year ResMed grew earnings per share by 13% and had a gross margin of 64.7%.

The company’s compounded annual growth rate over the last five years has been an incredible 13% and although this may start to slow the company still has positive demographics to help propel future growth.

Global Health Limited  (ASX: GLH) is a smaller company with significant growth potential. The company offers cloud-based software services for hospital operators and was identified by fellow Fool Owen Raskiewicz as his top pick for January this year. Since then shares have rocketed 62% on a great half-year result with revenue up 22% and NPAT up 38%.

Foolish takeaway

The healthcare industry has got off to a cracking start in 2014. Many of these companies cover a diverse range of businesses and are likely to continue to reap the rewards of changing demographics in the years to come, they should be considered part of your long-term growth portfolio.

The top ASX pick you've never heard of...

Top Motley Fool analysts just identified their #1 ASX pick for 2014, a small-cap stock that could be poised for big gains (and offers a fat, fully franked dividend!). Discover all the details now, including the name and code, in this FREE investment report, "The Motley Fool's Top Stock for 2014."

Motley Fool contributor Regan Pearson does not own shares in any company mentioned.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.